Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2024 Jul 27;404(10450):339-340.
doi: 10.1016/S0140-6736(24)01049-3.

Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial - Authors' reply

Hope S Rugo  1 , Aditya Bardia  2 , Sara Tolaney  3
Affiliations
Comment

Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial - Authors' reply

Hope S Rugo et al. Lancet. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

HSR has received grants or contracts (institutional) from AstraZeneca, Daiichi Sankyo, F Hoffmann-La Roche/Genentech, Gilead Sciences, Lilly, Merck, Novartis, Pfizer, OBI Pharma, Stemline Therapeutics, and Ambryx; and consultancy, advisory support (personal), or honoraria from NAPO, Mylan, Chugai, and Puma. AB has received support (personal) for participation in advisory boards for AstraZeneca/Daiichi, Eisai, Genentech, Gilead Sciences, Lilly, Menarini, Merck, Mersana, Novartis, Pfizer, and Sanofi; and received funding (institutional) and consulting fees from AstraZeneca/Daiichi, Eli Lilly, Genentech, Gilead Sciences, Menarini, Merck, Novartis, Pfizer, and Sanofi. ST has received grants or contracts (institutional) from AstraZeneca, Bristol Myers Squibb, Eisai, Exelixis, Genentech/Roche, Gilead Sciences, Lilly, Merck, NanoString Technologies, Novartis, OncoPep, Pfizer, and Seattle Genetics; consulting fees (personal) from AADi, Artios, Arvinas, AstraZeneca, Bayer, BioNTech, Blueprint Medicines, Bristol Myers Squibb, Circle Pharma, Cullinan Oncology, CytomX Therapeutics, Daiichi Sankyo, eFFECTOR, Eisai, Genentech/Roche, Hengrui USA, Immunomedics/Gilead, Incyte, Jazz Pharmaceuticals, Johnson & Johnson, Lilly, Menarini Group, Merck, Natera, Novartis, Pfizer, Reveal Genomics, Sanofi, Seagen, Sumitovant Biopharma, Systimmune, Tango Therapeutics, Umoja Biopharma, Zentalis, and Zymeworks; and received support for attending meetings or travel (personal) from Gilead Sciences, Jazz Pharmaceuticals, Lilly, and Sanofi.

Comment on

References

MeSH terms